期刊文献+

银杏酮酯滴丸治疗急性冠脉综合征的疗效观察 被引量:2

Efficacy Observation of Ginkgo Biloba Extract Dripping Pill in the Treatment of Acute Coronary Syndrome
下载PDF
导出
摘要 目的:探讨银杏酮酯滴丸治疗急性冠脉综合征的临床疗效。方法:选择2011年7月-2013年12月笔者所在医院收治的92例急性冠脉综合征患者,随机分为治疗组49例和对照组43例,治疗组给予银杏酮酯滴丸治疗,对照组给予常规药物硝酸异山梨酯片治疗。连续治疗8周,观察疗效。结果:在心绞痛改善情况方面,治疗组总有效率为89.80%,显著高于对照组的65.12%;在心电图改善情况方面,治疗组总有效率为77.55%,显著高于对照组的53.49%;治疗组血流变改善情况也显著优于对照组(P<0.05)。结论:应用银杏酮酯滴丸治疗急性冠脉综合征,其疗效可靠,患者耐受性好,具有极大的推广应用价值。 Objective:To investigate the clinical curative effect of Ginkgo Biloba Extract Dripping Pill in the treatment of acute coronary syndrome. Method:92 cases with acute coronary syndrome in author’s hospital from July 2011 to December 2013 were selected,were randomly divided into treatment group and control group,the treatment group received the Ginkgo Biloba Extract Dripping Pill treatment,the control group was given routine drug of Isosorbide Mononitrate Tablets treatment.The patients of two groups were treated for 8 weeks in duration,the curative effect was observed.Result:In the improvement of angina,the total efficiency rate of treatment group was 89.80%,significantly higher than the control group with 65.12%.In the improvement of ECG,the total efficiency rate of treatment group was 77.55%,significantly higher than the control group with 53.49%.The blood rheology improve of treatment group was significantly better than the control group(P〈0.05).Conclusion:The application of Ginkgo Biloba Extract Dripping Pill in the treatment of acute coronary syndrome, its curative effect is reliable,patients’tolerance is good,has great application value.
机构地区 东莞市长安医院
出处 《中外医学研究》 2014年第14期5-7,共3页 CHINESE AND FOREIGN MEDICAL RESEARCH
关键词 银杏酮酯滴丸 急性冠脉综合征 心绞痛 Ginkgo Biloba Extract Dripping Pill Acute coronary syndrome Angina
  • 相关文献

参考文献9

二级参考文献42

  • 1蒋立新.静脉β受体阻滞剂在心血管急症中的应用[J].中华心血管病杂志,2004,32(9):858-861. 被引量:91
  • 2王朋,张颖,范亚明,王绿娅,杜嘉会.水蛭、丹参对实验性动脉粥样硬化及纤溶系统的影响[J].心肺血管病杂志,1996,15(1):52-54. 被引量:60
  • 3王宏志.单硝酸异山梨酯治疗冠心病心绞痛的疗效观察[J].中国校医,2006,20(4):423-424. 被引量:5
  • 4中华中医药学会.中医内科常见病诊疗指南.北京:中国中医药出版社,2008:294-296.
  • 5Yusuf S,Peto R,Lewis J,et al.Beta blockade during and after myocardial infarction:An overview of the randomized trials[J].Prog Cardiovasc Dis,1985,27:335-371.
  • 6Steven B,Mihai G.Early intravenous beta-blocker combined with thrombolytic therapy for acute myocardial infarction(TIMI-Ⅱ)trial[J].Progress in Cardiovascular Diseases,1993,3:261-266.
  • 7Colucci WS.Molecular and cellular mechanisms of myocardial failure[J].Am J Cardiol,1997,80(11A):15L-25L.
  • 8Shizukuda Y,Buttrick PM,Geenen D,et al.Beta-adrenergic stimulation causes cardiocyte apoptosis:Influence of tachycardia and hypertrophy[J].Am J Physiol,1998,275:961-968.
  • 9Green GB,Beaudreau RW,Chan DW,et al.Use of troponin I and creatine kinase-MB subnit levels for risk stratification of emergency department patients with possible myocardial ischemia[J].Ann Emerg Med,1998,31:19-29.
  • 10Wager I,Mair J,Fridrich L,et al.Cardiac troponin T release in acute myocardial infarction is associated with scintigraphic estimates of myocardial scar[J].Coronary Artery Dis,1993,4:537-544.

共引文献55

同被引文献13

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部